Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Government Administration Activities

U.S. Food and Drug Administration (FDA)
Cancer / National

FDA Approves New Treatment for Advanced Endometrial Cancer

June 20, 2024June 19, 2024 - by Maryann Pugh

WASHINGTON, D.C. — On Friday, the Food and Drug Administration (FDA) approved durvalumab (Imfinzi, AstraZeneca UK Limited) for use with carboplatin plus paclitaxel followed by single-agent durvalumab. This approval targets …

FDA Approves New Treatment for Advanced Endometrial Cancer Read More

U.S. Food and Drug Administration
Cancer / National

FDA Approves Blinatumomab for Advanced Leukemia Treatment

June 19, 2024June 19, 2024 - by Maryann Pugh

WASHINGTON, D.C. — On Friday, the Food and Drug Administration (FDA) approved blinatumomab (Blincyto, Amgen Inc.) for both adult and pediatric patients one month and older with CD19-positive Philadelphia chromosome-negative …

FDA Approves Blinatumomab for Advanced Leukemia Treatment Read More
Health / Medical / Products and Services

FDA Approves Expanded Use for Almirall’s Klisyri in Actinic Keratosis Treatment

June 17, 2024June 17, 2024 - by Timothy Alexander

MALVERN, PA — Almirall announced that the U.S. Food and Drug Administration (FDA) recently approved an expansion for its drug Klisyri, allowing it to be used over a larger surface …

FDA Approves Expanded Use for Almirall’s Klisyri in Actinic Keratosis Treatment Read More

Yogurt with cottage cheese and jam
National

FDA Proposes Exemption for Cottage Cheese from Traceability Rules

June 17, 2024June 15, 2024 - by Maryann Pugh

WASHINGTON, D.C. — On Friday, the U.S. Food and Drug Administration proposed an exemption for certain cottage cheese products from the Food Traceability Rule. This rule mandates extra recordkeeping for …

FDA Proposes Exemption for Cottage Cheese from Traceability Rules Read More
Food and Drug Administration
National

FDA Issues Warning Letters to Companies Selling Unapproved Animal Drug

June 16, 2024June 15, 2024 - by Maryann Pugh

WASHINGTON, D.C. — On Tuesday, the FDA issued warning letters to four companies marketing the unapproved animal drug toltrazuril. The companies involved are All Things Bunnies Inc., Linessa Farms LLC, …

FDA Issues Warning Letters to Companies Selling Unapproved Animal Drug Read More

Traffic
Pennsylvania

Pennsylvania Upgrades 511PA Travel Information Service for Better User Experience

June 2, 2024June 2, 2024 - by Maryann Pugh

HARRISBURG, PA — The Pennsylvania Department of Transportation (PennDOT) and the Pennsylvania Turnpike Commission (PA Turnpike) have unveiled significant upgrades to 511PA, the state’s free, statewide travel information service. This …

Pennsylvania Upgrades 511PA Travel Information Service for Better User Experience Read More
U.S. Food and Drug Administration
National

FDA Approves Bkemv, A Potentially Game-Changing Treatment for Rare Blood Diseases

June 2, 2024June 2, 2024 - by Maryann Pugh

WASHINGTON, D.C. — In a significant advancement for patients with rare blood diseases, the U.S. Food and Drug Administration (FDA) has given its nod to Bkemv (eculizumab-aeeb), the first interchangeable …

FDA Approves Bkemv, A Potentially Game-Changing Treatment for Rare Blood Diseases Read More

Pennsylvania Department of Labor and Industry
Pennsylvania

Pennsylvania’s UC Connect Program: A Bright Spot in Unemployment Compensation

June 2, 2024June 2, 2024 - by Maryann Pugh

HARRISBURG, PA — In dealing with unemployment compensation issues, the Commonwealth of Pennsylvania has become a shining beacon of success, particularly through the efforts of the Shapiro Administration and the …

Pennsylvania’s UC Connect Program: A Bright Spot in Unemployment Compensation Read More
Larimar Therapeutics
Regional

Larimar Therapeutics Advances Friedreich’s Ataxia Treatment After FDA Lifts Hold

May 21, 2024May 21, 2024 - by Timothy Alexander

BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) announced this week that the U.S. Food and Drug Administration (FDA) has removed the partial clinical hold on its nomlabofusp (CTI-1601) …

Larimar Therapeutics Advances Friedreich’s Ataxia Treatment After FDA Lifts Hold Read More
Neuronetics, Inc
Mental Health / Products and Services

FDA Clears NeuroStar TMS Therapy for Adolescents with Depression, A First in the Field

May 2, 2024May 1, 2024 - by Timothy Alexander

MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced that the U.S. Food and Drug Administration (FDA) has cleared NeuroStar TMS (transcranial magnetic stimulation) for use as a first-line add-on …

FDA Clears NeuroStar TMS Therapy for Adolescents with Depression, A First in the Field Read More

Posts pagination

Previous 1 … 11 12 13 … 15 Next

Trending News

  • PA House Panel to Weigh Bill Requiring Anti-Trafficking Training for Hospitality Workers

  • OURfest Returns to Philly With Bold Theme for National Coming Out Day

  • New Hope Arts and Crafts Festival Returns for 31st Year With Over 160 Artists

  • Warren County Man Sentenced to Up to 40 Years for Child Exploitation Crimes

  • North Wales Man Gets Four Years for $72 Million Loan Fraud Scheme

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Prison

Warren County Man Sentenced to Up to 40 Years for Child Exploitation Crimes

September 24, 2025September 24, 2025

United States Penitentiary

North Wales Man Gets Four Years for $72 Million Loan Fraud Scheme

September 24, 2025September 24, 2025

Court News

Philadelphia Real Estate Agent Pleads Guilty in $3M Fraudulent Loan Scheme

September 24, 2025September 24, 2025

Copyright © 2025 MyChesCo.